Mevalonate Blockade in Cancer Cells Triggers CLEC9A(+) Dendritic Cell-Mediated Antitumor Immunity. Xu F, Wang Z, Zhang H, Chen J, et al. Cancer Res 2021;81:4514-4528.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu F, Wang Z, Zhang H, Chen J, et al. Mevalonate Blockade in Cancer Cells Triggers CLEC9A(+) Dendritic Cell-Mediated Antitumor Immunity. Cancer Res 2021;81:4514-4528.
PMID: 34266895